glp-1 surgery complications Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement GLP-1 agonists may not increase

July 27, 2026: FDA peptide panel narrowly votes to add unapproved drugs to compounding list Major Stories The FDAs peptide panel voted to add six unapproved compounds to the 503A bulks compounding list, despite agency scientists' warnings about the consequences

The blend delivers 330 mcg per day (2,310 mcg per week on a 7-day schedule), which aligns with the lower end of maintenance dosing

However, patients may be required to consume a high-calorie diet to prevent excessive weight loss while on treatment

The medication is FDA approved to treat hypoactive sexual desire disorder (HSDD) in premenopausal women

Sitagliptin/metformin is a combination of sitagliptin and metformin, and Janumet is one of the brand names for this combination medication